Stay updated on Setmelanotide in LEPR Deficiency Obesity Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page.

Latest updates to the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoChange DetectedRemoved the 403 Forbidden page that previously blocked access to the study details on ClinicalTrials.gov, restoring the ability to view the study record.SummaryDifference0.5%

- Check15 days agoChange DetectedA 403 Forbidden page is now shown for the study record, indicating access is blocked and replacing the prior study content view.SummaryDifference19%

- Check22 days agoChange DetectedRevision: v3.7.0 has been added, replacing v3.6.6. This appears to be a frontend/template update and does not change the study details or eligibility information.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page's revision was updated from v3.6.5 to v3.6.6, signaling a small patch to the site’s content or UI rather than a substantive change to study information.SummaryDifference0.1%

- Check43 days agoChange DetectedThe official title includes a 2017 NIH grant/contract funding attribution, updating the study’s identifying information to reflect funding source.SummaryDifference0.1%

Stay in the know with updates to Setmelanotide in LEPR Deficiency Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page.